CMS unveils the GENERous Medicaid payment model introducing MFN drug pricing, alongside expanded Trump administration drug pricing agreements and key regulatory updates for 2026.

Banner Health's insurance plan integrates health system data and AI technology to improve care coordination, compliance, and member experience in Medicare and Medicaid markets.

Explore how rural hospitals are adapting to Medicaid cuts and workforce challenges through innovation and targeted strategies to maintain healthcare access in rural America.

Novo Nordisk and Eli Lilly agree to lower GLP-1 drug prices in exchange for expanded Medicare and Medicaid coverage, marking a major shift in U.S. drug pricing and access.

Congressional deadlock jeopardizes ACA premium subsidies, increasing health insurance costs and risking a rise in uninsured Americans in 2026. Understand implications for healthcare access, Medicaid cuts, and economic inequality.

The Trump administration announces agreements with Eli Lilly and Novo Nordisk to lower prices and expand Medicare coverage for weight-loss drugs like Wegovy and Zepbound, effective 2026.

Explore the impact of Medicaid funding cuts, Louisiana's insurance market challenges, and environmental monitoring laws, alongside public program funding shifts in Colorado and housing market trends affecting U.S. insurance professionals.

The 2026 ACA open enrollment starts as enhanced premium tax credits expire, causing premium hikes and coverage losses for millions, especially marginalized groups.

Ballad Health sues UnitedHealth Group over alleged Medicare Advantage care denials, coding practices, and reimbursement disputes impacting rural healthcare and insurance contracts.

Explore the escalating strain on U.S. emergency rooms due to risk of ACA subsidy expirations and significant Medicaid cuts, impacting healthcare access and costs nationwide.